Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 08, 2020

SELL
$6.28 - $14.57 $324,048 - $751,812
-51,600 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$6.5 - $10.73 $7,800 - $12,876
1,200 Added 2.38%
51,600 $99,000
Q3 2019

Nov 12, 2019

BUY
$8.75 - $12.85 $441,000 - $647,640
50,400 New
50,400 $80,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $155M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.